Skip Nav Destination
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin
Issue Archive
October 15 2007
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
REVIEW ARTICLES
ERRATUM
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Clinical Trials & Observations
Catherine M. Bollard,Stephen Gottschalk,Ann M. Leen,Heidi Weiss,Karin C. Straathof,George Carrum,Mariam Khalil,Meng-fen Wu,M. Helen Huls,Chung-Che Chang,M. Victoria Gresik,Adrian P. Gee,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop
GENE THERAPY
HEMATOPOIESIS
TGF-β combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors
Geling Li,Saeid Abediankenari,Young-June Kim,Timothy B. Campbell,Shigeki Ito,Barbara Graham-Evans,Scott Cooper,Hal E. Broxmeyer
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Functional interplay between endothelial nitric oxide synthase and membrane type 1–matrix metalloproteinase in migrating endothelial cells
Laura Genís,Pilar Gonzalo,Antonio S. Tutor,Beatriz G. Gálvez,Antonio Martínez-Ruiz,Carlos Zaragoza,Santiago Lamas,Karl Tryggvason,Suneel S. Apte,Alicia G. Arroyo
IMMUNOBIOLOGY
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies
Ingrid G. Schuster,Dirk H. Busch,Elfriede Eppinger,Elisabeth Kremmer,Slavoljub Milosevic,Christine Hennard,Christina Kuttler,Joachim W. Ellwart,Bernhard Frankenberger,Elfriede Nößner,Christoph Salat,Christian Bogner,Arndt Borkhardt,Hans-Jochem Kolb,Angela M. Krackhardt
Inactivation of PI3Kγ and PI3Kδ distorts T-cell development and causes multiple organ inflammation
Hong Ji,Felix Rintelen,Caroline Waltzinger,Dominique Bertschy Meier,Antonio Bilancio,Wayne Pearce,Emilio Hirsch,Matthias P. Wymann,Thomas Rückle,Montserrat Camps,Bart Vanhaesebroeck,Klaus Okkenhaug,Christian Rommel
Critical role of FLT3 ligand in IL-7 receptor–independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors
Ewa Sitnicka,Natalija Buza-Vidas,Henrik Ahlenius,Corrado M. Cilio,Christos Gekas,Jens M. Nygren,Robert Månsson,Min Cheng,Christina T. Jensen,Marcus Svensson,Karin Leandersson,William W. Agace,Mikael Sigvardsson,Sten Eirik W. Jacobsen
NEOPLASIA
Chromosomal abnormalities in Philadelphia chromosome–negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase
Elias Jabbour,Hagop M. Kantarjian,Lynne V. Abruzzo,Susan O'Brien,Guillermo Garcia-Manero,Srdan Verstovsek,Jianqin Shan,Mary Beth Rios,Jorge Cortes
The molecular signature of MDS stem cells supports a stem-cell origin of 5q− myelodysplastic syndromes
Lars Nilsson,Patrik Edén,Eleonor Olsson,Robert Månsson,Ingbritt Åstrand-Grundström,Bodil Strömbeck,Kim Theilgaard-Mönch,Kristina Anderson,Robert Hast,Eva Hellström-Lindberg,Jan Samuelsson,Gösta Bergh,Claus Nerlov,Bertil Johansson,Mikael Sigvardsson,Åke Borg,Sten Eirik W. Jacobsen
Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin
Brief Report
Susanna Fischer,Georg Mann,Marianne Konrad,Markus Metzler,Georg Ebetsberger,Neil Jones,Bertrand Nadel,Olaf Bodamer,Oskar A. Haas,Klaus Schmitt,E. Renate Panzer-Grümayer
PHAGOCYTES
HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA–forming microsatellite
Henry K. Bayele,Carole Peyssonnaux,Alexandra Giatromanolaki,Wagner W. Arrais-Silva,Hiba S. Mohamed,Helen Collins,Selma Giorgio,Michael Koukourakis,Randall S. Johnson,Jenefer M. Blackwell,Victor Nizet,Surjit Kaila S. Srai
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSPLANTATION
One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation
Veronique Erard,Katherine A. Guthrie,Cara Varley,Judson Heugel,Anna Wald,Mary E. D. Flowers,Lawrence Corey,Michael Boeckh
CORRESPONDENCE
-
Cover Image
Cover Image
Expression of cell surface nucleolin (red) in a colorectal tumor. The section was costained with an antibody to PECAM-1 (CD31; green) to mark blood vessels and with DAPI to mark cell nuclei. See the related article by Shi et al, beginning on page 2899.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals